DexCom, Inc. DXCM
Regular-session close
After hours · Nov 20, 7:54 PM ET
- YTD
- +19.51%
- 1 year
- +35.78%
Held by funds
483 US ETFs and mutual funds hold DXCM · largest positions
- VOO 0.05% of fund $824.91M
- VTI 0.04% of fund $778.25M
- QQQ 0.15% of fund $670.51M
- VO 0.30% of fund $663.37M
- FXAIX 0.05% of fund $423.18M
- IVV 0.05% of fund $419.10M
- VUG 0.11% of fund $415.52M
- SPY 0.05% of fund $378.80M
- VGHCX 0.71% of fund $271.45M
- VOT 0.75% of fund $242.41M
- XLV 0.47% of fund $227.13M
- RSP 0.20% of fund $201.10M
- NIW 0.92% of fund $188.85M
- IWP 1.00% of fund $175.07M
- VINIX 0.05% of fund $163.21M
- IHI 3.94% of fund $157.04M
- QQQM 0.15% of fund $153.77M
- IWR 0.23% of fund $132.75M
- KMD 4.28% of fund $126.78M
- FSMDX 0.24% of fund $124.98M
Ownership
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 10.32% | 38,498,188 | 3.05B | Sep 29, 2026 |
| Vanguard Capital Management LLC | 6.62% | 24,704,482 | 1.96B | Sep 29, 2026 |
| Vanguard Portfolio Management LLC | 5.31% | 19,791,156 | 1.57B | Sep 29, 2026 |
| State Street Corporation | 5.07% | 18,896,988 | 1.50B | Sep 29, 2026 |
| Invesco Ltd. | 4.28% | 15,968,909 | 1.27B | Sep 29, 2026 |
| BAILLIE GIFFORD & CO | 3.89% | 14,521,620 | 1.15B | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.28% | 12,250,468 | 971.71M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.68% | 10,000,154 | 793.21M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund | 2.24% | 8,360,947 | 663.19M | Jun 29, 2026 |
| Invesco QQQ Trust, Series 1 | 2.11% | 7,879,739 | 625.02M | Sep 29, 2026 |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 1.44% | 5,384,037 | 427.06M | Jul 30, 2026 |
| iShares Trust-iShares Core S&P 500 ETF | 1.35% | 5,028,467 | 398.86M | Sep 29, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs DXCM, and what each was last paid
Jacob Steven Leach, President, CEO & DirectorAverage age 54
| Name | Title | Pay | Age |
|---|---|---|---|
| Jacob Steven Leach | President, CEO & Director | $2.05M | 48 |
| Kevin Ronald Sayer | Executive Chairman of the Board | $2.43M | 68 |
| Jereme Sylvain | Executive VP, CFO, COO & Chief Accounting Officer | $1.14M | 46 |
| Michael Brown | Executive VP, Chief Legal & Compliance Officer | $1.10M | 56 |
| Jon Coleman | Executive Vice President & Chief Commercial Officer | $1.01M | 62 |
| Sadie Stern | Executive VP, Chief People & Culture Officer | $1.01M | 51 |
| Peter Simpson | Executive Vice President & Chief Technology Officer | $424K | — |
| Christine Pospisil | Director of Medical Science & Education | — | — |
| Keri Leone | Senior Director of Global Medical Science & Education | — | — |
| Matthew Dolan | Executive Vice President of Strategy & Corporate Development | — | 45 |
| Sean Christensen | Vice President of Finance and Investor Relations | — | — |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ALTMAN STEVEN R | Director | Stock Award(Grant) | May 27, 2026 | 69,232 |
| BROWN MICHAEL JON | Officer | Sale | Nov 15, 2026 | 95,034 |
| COLEMAN JON | Officer | Sale | Jun 3, 2026 | 95,450 |
| COLLINS RICHARD ALEXANDER | Director | Stock Award(Grant) | May 27, 2026 | 45,767 |
| FOLETTA MARK G | Director | Sale | Aug 2, 2026 | 0 |
| LEACH JACOB STEVEN | Chief Executive Officer | Stock Award(Grant) | Mar 5, 2026 | 469,106 |
